TotalSeq™-C Custom Human Panel; 53 reactions

This solicitation seeks a custom TotalSeq-C human antibody panel from BioLegend consisting of 53 reactions targeting 111 cell surface and intracellular markers for human immune cell analysis. The National Heart, Lung and Blood Institute of the National Institutes of Health requires the panel for research use and specifies packaging, documentation, and manufacturing requirements. Proposals are due by November 30, 2023 and the agency will evaluate based on the supplier's ability to meet the stated research needs and technical specifications.

There is no set-aside designation for this requirement. The NAICS code is 325414 and PSC code is Q2DX. BioLegend is identified as the potential incumbent. The specification form attached to the solicitation lists the antibody targets and recommended concentrations in detail. The total value is unspecified but the panel size is 11 pouches containing 5 reactions each, for a total of 53 reactions. Performance will take place in Bethesda, Maryland.